Wang, J.; Wang, Y.; Pan, H.; Zhao, L.; Yang, X.; Liang, Z.; Shen, X.; Zhang, J.; Yang, J.; Zhu, Y.;
et al. Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma. Int. J. Mol. Sci. 2023, 24, 5424.
https://doi.org/10.3390/ijms24065424
AMA Style
Wang J, Wang Y, Pan H, Zhao L, Yang X, Liang Z, Shen X, Zhang J, Yang J, Zhu Y,
et al. Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma. International Journal of Molecular Sciences. 2023; 24(6):5424.
https://doi.org/10.3390/ijms24065424
Chicago/Turabian Style
Wang, Jing, Yanan Wang, Hanyu Pan, Lin Zhao, Xinyi Yang, Zhiming Liang, Xiaoting Shen, Jing Zhang, Jinlong Yang, Yuqi Zhu,
and et al. 2023. "Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma" International Journal of Molecular Sciences 24, no. 6: 5424.
https://doi.org/10.3390/ijms24065424
APA Style
Wang, J., Wang, Y., Pan, H., Zhao, L., Yang, X., Liang, Z., Shen, X., Zhang, J., Yang, J., Zhu, Y., Xun, J., Liang, Y., Lin, Q., Liang, H., Li, M., & Zhu, H.
(2023). Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma. International Journal of Molecular Sciences, 24(6), 5424.
https://doi.org/10.3390/ijms24065424
